Patents
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
04/2004
04/01/2004US20040063684 Treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
04/01/2004US20040063665 Anticancer agents; high degree of discrimination toward malignant cells; reducing side effects; nontoxic; such as 3-chloro-2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-4H-chromen-4-one
04/01/2004US20040062713 Dye; photosensitive stimulant; using eye
04/01/2004DE10244282A1 Zubereitung mit antioxidanten Eigenschaften Composition having antioxidant properties
04/01/2004DE10243906A1 9-Cyanosubstituierte Perylen-3,4-dicarbonsäuremonoimide 9-cyano-substituted perylene-3,4-dicarboxylic monoimides
03/2004
03/31/2004EP1401962A1 Method for increasing hydrophilicity of fluorescent label compounds
03/31/2004EP1401823A1 Substituted benzopyran derivatives against arrhythmia
03/31/2004EP1401575A1 Hydroxylation of beta-dicarbonyls with zirconium catalysts
03/31/2004EP1114041B1 Process for the preparation of alpha-tocopherol acetate
03/31/2004EP1019453B1 Aromatic-substituted xanthene dyes
03/31/2004CN1485325A Soybean extract with health-care function , its preparing process and use
03/31/2004CN1485324A Method of membrane separation technique for producing seabuckthorn flavone
03/31/2004CN1143857C Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors
03/31/2004CN1143854C Novel 2-(iminomethyl) amino-phenyl derivatives,the preparation thereof, application as medicines and pharmaceutical compositions containing same
03/30/2004US6713622 Contacting a 4,7-dichlororhodamine dye comprising a linking group with a polynucleotide comprising a terminal functionality complementary to the linking group
03/30/2004US6713508 Such as 7-(3-(3-trifluoromethyl-7-propyl-6-benz-(4,5)-isoxazoloxy)propoxy)-2 -ethylchromane-2-carboxylic acid which are potent agonists of peroxisome proliferator activated receptor
03/30/2004US6713506 Inhibiting proteasomal chymotrypsin-like activity
03/30/2004US6713228 Unsaturated ether containing polymer
03/30/2004US6713146 Singly recordable compact disc (cd-r)
03/30/2004CA2143441C Recovery of tocopherol and sterol
03/30/2004CA2102812C Cholesterol-lowering tocopherol analogs
03/25/2004WO2004025259A2 Site-specific labeling of affinity tags in fusion proteins
03/25/2004WO2004024709A2 Xanthenyl cubane analogs with activity at the metabotropic glutamate receptors
03/25/2004WO2004024140A1 Efflux pump inhibitors
03/25/2004WO2004024093A2 Device and method for treating restenosis
03/25/2004WO2004024081A2 Acetyl 2-hydroxy-1,3 diaminoalkanes
03/25/2004WO2003060852A3 Catalytic osmium-assisted oxidative cleavage of olefins
03/25/2004WO2003040134A9 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof
03/25/2004US20040059145 Heterodiamondoids
03/25/2004US20040059136 7-carboxy-flavone derivatives preparation method and therapeutic use
03/25/2004US20040059116 Aryl aniline beta2 adrenergic receptor agonists
03/25/2004US20040059100 Metallating 2-hydroxyacetophenone compound using a lithium compound and subsequently reacted with a keto compound such as 3,4-dimethoxybenzoyl chloride; specific stoichiometry of Li compound
03/25/2004US20040058987 Hypotensive agents; oxidation resistance, nitrogen scavenger; anticancer agents; antiischemic agents
03/25/2004US20040058986 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
03/25/2004US20040058985 Coumarin analog compounds for safer anticoagulant treatment
03/25/2004US20040058937 Heterocyclic mutilin esters and their use as antibacterials
03/25/2004US20040058931 Potassium channel inhibitors and method
03/25/2004DE10243234A1 New tocopheryl esters of aminoacids or derivatives, useful in cosmetic or dermatological compositions, e.g. for protecting skin against osmotic and oxidative stress and/or treating inflammation
03/25/2004CA2498248A1 Acetyl 2-hydroxy-1,3 diaminoalkanes
03/24/2004EP1400579A2 Composition with anti-oxidative properties
03/24/2004EP1399406A2 Novel estrogen receptor ligands and methods i
03/24/2004EP1315711B1 Method for producing dihydrocoumarin by hydrogenating coumarin
03/24/2004EP0912543B1 Crystalline (-)-3r,4r-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-[4- 2-(pyrrolidin-1-yl)ethoxy]phenyl chromane, hydrogen fumarate
03/24/2004EP0904079B1 Antidiabetic agents
03/24/2004CN1142928C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
03/24/2004CN1142927C Chalcone coumarins
03/23/2004US6710208 Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and α,β-unsaturated carboxylic acid and aldehyde compounds
03/23/2004US6710188 Chemically amplified resist, polymer for the chemically amplified resist, monomer for the polymer and method for transferring pattern to chemically amplified resist layer
03/23/2004CA2101575C New cycloalkylalkylamines which are sigma-receptor ligands, process for preparing them and their application in therapy
03/18/2004WO2004022703A2 Non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents
03/18/2004WO2004022550A1 Compound for treatment of anxiety and methods of preparation and use thereof
03/18/2004WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/18/2004WO2004021969A2 Non-nucleoside reverse transcriptase inhibitors
03/18/2004WO2004007475A8 Flavonoid compounds as therapeutic antioxidants
03/18/2004WO2003086563A3 Diabetes imaging probes
03/18/2004US20040054195 Fluorescent dyes; photostability; labels, staining; analysis
03/18/2004US20040053992 Methods for producing chiral chromones, chromanes, amino substituted chromanes and intermediates therefor
03/18/2004US20040053935 Anticancer agents
03/18/2004US20040053934 Anticancer agents
03/18/2004US20040053859 Preventive or therapeutic agent for cancer containing cyanidin compound as active ingredient
03/18/2004US20040053858 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
03/18/2004US20040053383 Crystals of cytochrome P450 2C9, structures thereof and their use
03/18/2004US20040053217 Using conjugate agents comprise of photoreactive moiety to identify preferential micro and/or macromolecules in heterologous mixtures
03/18/2004CA2501924A1 Non-nucleoside reverse transcriptase inhibitors
03/18/2004CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/17/2004EP1309572A4 Silent mark for oil product and detection method thereto
03/17/2004CN1482126A Tea polyphenols extracting process
03/17/2004CN1482125A Process for extracting lotus leaf flavone
03/17/2004CN1482124A Preparation process for dragon's blood total flavonoids
03/17/2004CN1142155C Use of ampelopsin for preparing antileukemie and anti-nasopharyngeal carcinoma medicines
03/16/2004US6706898 Methods for separating a tocopherol from a tocopherol-containing mixture
03/16/2004US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors
03/16/2004US6706757 Chroman derivatives as 5-hydroxytryptamine-6 ligands
03/16/2004US6706292 Recovery of isoflavones from soy molasses
03/11/2004WO2004020428A1 Process for producing aminobenzopyran compound
03/11/2004WO2004020427A1 The process for preparation of total coumarins from cortex fraxini and their use in medicine
03/11/2004WO2004019888A2 Process to prepare psorospermin
03/11/2004WO2004019874A2 Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
03/11/2004US20040049059 Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts
03/11/2004US20040049056 Process for preparation of esculetin compounds, esculetin compounds and intermediates thereof, and use of both
03/11/2004CA2513021A1 Process to prepare psorospermin
03/11/2004CA2495192A1 Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
03/10/2004EP1395615A1 Oxime ester photoinitiators having a combined structure
03/10/2004EP1395596A2 Methods for preparation and use of psorospermin analogs
03/10/2004EP1395539A1 A method for isolating phenolic substances or juvabiones from wood comprising knotwood
03/10/2004EP1214309B1 Preparing amidines derived from 6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid
03/10/2004EP1124816B1 Products for body hygiene based on lapacho extracts containing quercitine, their preparation and use
03/10/2004EP1115717B1 3-(hydroxymethyl)chromen-4-ones and process for their preparation
03/10/2004EP0957911B1 HESPERIDIN AND HESPERETIN AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR
03/10/2004CN1481392A Surface-active photoinitiators
03/10/2004CN1480457A Method for extracting tea polyhenols and tea pigment
03/10/2004CN1480456A Method for picking-up general flavone from hawthorn fruit by using microwave
03/10/2004CN1480063A Method for producing base material of soybean isoflavone with sugariness taste
03/10/2004CN1141304C Method for preparing viatmin E
03/10/2004CN1141303C Process for enriching high-purity catechin
03/10/2004CN1141295C Indoline derivatives as progesterohe antagonists
03/09/2004US6703514 4-thio coumarins
03/09/2004US6703414 A stent comprised of a stent body coated with a compound of the following formula:with hetero compounds
03/09/2004US6703384 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
03/04/2004WO2004017997A1 Remedy or preventive for kidney disease and method of diagnosing kidney disease